The webinar “Optimising the treatment pathway in HER2-positive breast cancer: from neoadjuvant therapy to surgery” is a specialized educational session scheduled for February 2, 2026, at 18:00 CET.

Part of the European Union-funded DEFINITIVE project, this session examines the critical interface between systemic neoadjuvant management and evolving surgical standards for HER2-positive breast cancer. A multidisciplinary panel, including experts Monika Gräser and Gaia Griguolo with discussant Aleksandra Filipovic, will address evidence-based strategies for tailoring therapy and the clinical implications of treatment response on surgical decision-making.